Task: Answer the multiple-choice question.
Query: Which drug exhibits a 4.958% human ether-à-go-go related gene (hERG) inhibition at 10uM?
Constraint: You must select none, one or more options from a, b, or c without using any additional words.
Options:
a.) CN1CCCN(C(=O)COc2ccccc2Br)CC1
b.) COC(=O)Cc1[nH]c(Cl)nc1C(N)=O
c.) CC1CCC(C(C)C)C(OC(=O)C[n+]2cc(-c3ccc(Cl)cc3)n3c2CCC3)C1.[Cl-]
Answer: b. COC(=O)Cc1[nH]c(Cl)nc1C(N)=O
{#Task|Problem statement!}: Answer the {#multiple choice|multiple-choice|MCQ!} question.
{#Question|Query!}: Which {#compound|drug!} {#has|exhibits!} a {herg_central_at_10uM#}{herg_central_at_10uM__units} {herg_central_at_10uM__names__noun}?
Constraint: You must select none, one or more options from {%multiple_choice_enum%2-5%aA1} without using any {#other|additional!} words.
Options:
{SMILES%herg_central_at_10uM%}
Answer: {%multiple_choice_result}. {SMILES#}
COC(=O)Cc1[nH]c(Cl)nc1C(N)=O
COC(=O)Cc1[nH]c(Cl)nc1C(N)=O
methyl 2-(4-carbamoyl-2-chloro-1H-imidazol-5-yl)acetate